Transformation Capital

Activity from announced rounds

Activity in this selectionSeries A
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$101M
2 disclosed · full round size, not this investor’s share

By stage

Series A2

By primary sector

Healthtech2

By country

United States2

Rounds

2 in this selection
Solstice

AI-native marketing agency accelerating pharma commercialization

$21MSeries A
Role not disclosed
Latent

Develops a clinical-reasoning system for medication-access workflows.

$80MSeries A
Role not disclosed